Is ADHD Real? What a 600-Page Review Found (ADHD Part 2)

Listen through the publisher, then discuss the episode here or arrange an in-person Roundtable. Your city determines where to meet.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
A new 600-page UK review found there’s no blood test, scan or biological marker for ADHD. So what does an ADHD diagnosis actually tell you? In part 2 of our ADHD series, my daughter Dominique and I unpack the new Fonagy review, why using an ADHD diagnosis to explain the struggle becomes circular reasoning, and what brain scans, gene research and medication studies show. The struggle is real, and I’ll give you two simple exercises to turn a label into a description you can work from. Want to go deeper? I’m hosting a live Q&A on ADHD for members of Neurocycle Insiders, my new private community. Join as a founding member for the Q&A and weekly Prescriptions: https://neurocycle-insiders.circle.so/neurocycle-insiders On ADHD medication? Please don’t stop suddenly. Talk to your doctor first. In this episode: - Why the UK’s Fonagy review found no biological test for ADHD - Is ADHD overdiagnosed? Why August-born kids were about 30% more likely to be diagnosed - What the ENIGMA brain scan study really showed about the “ADHD brain” - What long-term ADHD medication research says about height, heart health and psychosis risk - A 10-second sentence test that turns “because I have ADHD” into something you can change - My 7-day attention map: where your focus holds, where it slips, and why New here? Start with ADHD Part 1, earlier in this feed. Want to read more from Drominique? https://dominiqueleaf.substack.com/ Resources: - This week’s Neurocycle Prescription: https://drleaf.com/neurocycle-app - Become a Neurocycle Certified Strategist: https://drleaf.com/certified-strategist - 1:1 Coaching with Dr. Leaf: https://drleaf.com/coaching-1-1 Research cited: - The Fonagy review (2026): https://assets.publishing.service.gov.uk/media/6ac7c305b016250bca013ac3/independent-review-into-prevalence-and-support-for-mental-health-conditions-ADHD-and-autism.pdf - Joanna Moncrieff’s response (2026): https://www.madinamerica.com/2026/10/fonagy-missed-opportunity/ - ENIGMA brain volume study (Hoogman, 2017): https://pubmed.ncbi.nlm.nih.gov/28219628/ - August birthdays and ADHD diagnosis (Layton, 2018): https://pmc.ncbi.nlm.nih.gov/articles/PMC6322209 - Stimulant study in healthy boys (Rapoport, 1978): https://doi.org/10.1126/science.341313 and follow-up (1980): https://doi.org/10.1001/archpsyc.1980.01780210091010 - MTA follow-up into adulthood (Swanson, 2017): https://doi.org/10.1111/jcpp.12684 - ADHD medication and heart disease (Zhang, 2023). The 4% is a relative risk increase per year of use, not 4% of people: https://doi.org/10.1001/jamapsychiatry.2023.4294 - Amphetamines and psychosis or mania (Moran, 2024). Measured recent use in hospitalized psychiatric patients, not long-term use in the general public: https://doi.org/10.1176/appi.ajp.20230329 - Methylphenidate for children (Cochrane, 2015), source of the percentages quoted: https://doi.org/10.1002/14651858.CD009885.pub2 and 2023 update: https://doi.org/10.1002/14651858.CD009885.pub3 This episode is brought to you by: Visit WaldenU.edu. Shopify: https://shopify.com/leaf Granola: https://granola.ai/drleaf Mint Mobile: So, what are you waiting for? New episodes every Monday and Thursday. If this supported you, follow the show and leave a rating. Connect with me: https://drleaf.com (https://drleaf.com/) | Instagram & TikTok: @drcarolineleaf
Episode information is provided by the publisher. Listening takes place on the publisher’s service.
Listen at the source ↗












